RSS

In Profile

Dr Alexandre Akoulitchev, Oxford BioDynamics, talks to EPM about biomarkers aiding diagnostics and new treatments more

Opinion

Simon Portman, Marks & Clerk Solicitors, outlines the work the company does advising pharmaceutical companies on intellectual property issues more

Opinion

Dr David Roblin, chief operating officer and director of scientific translation at the Francis Crick Institute in London, talks to EPM about the Institute’s recent partnership with GSK that will address a number of disease areas more

Opinion

Vaishali Kamat, head of digital health at Cambridge Consultants, talks product design and development for the digital side of health more

Opinion

Alastair Smith, Avacta Life Sciences, outlines the company’s work developing engineered alternatives to antibodies more

Opinion

Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, which captures cancer cells circulating in the blood and harvests those cells for analysis more

Opinion